The association between androgen levels and premature coronary artery disease in men

被引:31
作者
Turhan, Sibel [1 ]
Tulunay, Cansin [1 ]
Gulec, Sadi [1 ]
Ozdol, Cagdas [1 ]
Kilickap, Mustafa [1 ]
Altin, Timucin [1 ]
Gerede, Menekse [1 ]
Erol, Cetin [1 ]
机构
[1] Ankara Univ, Sch Med, Dept Cardiol, TR-06100 Ankara, Turkey
关键词
androgen levels; male; premature coronary artery disease;
D O I
10.1097/MCA.0b013e328012a928
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective The relationship between androgens and the risk of development of coronary artery disease has not been clarified well. This study was planned to determine the relationship between serum androgen levels and premature development of coronary artery disease in men. Methods Sixty-nine men below 45 years of age with documented coronary artery disease (mean age 41.0 +/- 4.7) constituted the study group. Control group consisted of 56 men with similar age and normal coronary angiograms (mean age 41.3 +/- 3.8). Total and free testosterone, estradiol, and fasting plasma total, low-density lipoprotein, and high-density lipoprotein cholesterol, and triglyceride levels were measured, and compared between the two groups. Results Mean age, body mass index, and the frequency of hypertension were similar between the two groups; however, diabetes mellitus, smoking, hyperlipidemia, and family history of coronary artery disease were more frequent in the coronary artery disease group. Total and free testosterone levels of the patients with coronary artery disease were significantly lower than those of controls, whereas estradiol levels did not differ. Multivariate logistic regression analysis revealed that free testosterone levels (P=0.014; odds ratio=0.90; 95% confidence interval =0.87-0.99), hyperlipidemia (P < 0.001; odds ratio=8.2; 95% confidence interval =3.17-21.0), and smoking (P=0.026; odds ratio=3.12; 95% confidence interval= 1.15-8.48) were independent predictors of premature coronary artery disease. Moreover, using receiver operating characteristic analysis, patients with free testosterone levels below the cut-off value of 17.3 pg/ml had an adjusted 3.3-fold risk of developing premature coronary artery disease compared to those with free testosterone levels above the cut-off level (odds ratio= 3.3; 95% confidence interval= 1.57-6.87). Conclusion A low level of free testosterone may be related to the development of premature coronary artery disease. Coron Artery Dis 18:159-162 (C) 2007 Lippincott Williams & Wilkins.
引用
收藏
页码:159 / 162
页数:4
相关论文
共 27 条
[1]   The relationship of natural androgens to coronary heart disease in males: A review [J].
Alexandersen, P ;
Haarbo, J ;
Christiansen, C .
ATHEROSCLEROSIS, 1996, 125 (01) :1-13
[2]  
Alexandersen P, 1999, CIRC RES, V84, P813
[3]   Cardiovascular effects of testosterone: implications of the "male menopause"? [J].
Channer, KS ;
Jones, TH .
HEART, 2003, 89 (02) :121-122
[4]   SEX-HORMONES AND CORONARY-ARTERY DISEASE [J].
CHUTE, CG ;
BARON, JA ;
PLYMATE, SR ;
KIEL, DP ;
PAVIA, AT ;
LOZNER, EC ;
OKEEFE, T ;
MACDONALD, GJ .
AMERICAN JOURNAL OF MEDICINE, 1987, 83 (05) :853-859
[5]  
Costarella CE, 1996, J PHARMACOL EXP THER, V277, P34
[6]  
DOUGLAS PS, 1997, HEART DIS TXB CARDIO, P1704
[7]   Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina - A randomized, double-blind, placebo-controlled study [J].
English, KM ;
Steeds, RP ;
Jones, TH ;
Diver, MJ ;
Channer, KS .
CIRCULATION, 2000, 102 (16) :1906-1911
[8]   Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms [J].
English, KM ;
Mandour, O ;
Steeds, RP ;
Diver, MJ ;
Jones, TH ;
Channer, KS .
EUROPEAN HEART JOURNAL, 2000, 21 (11) :890-894
[9]   INSULIN-RESISTANCE, BODY-FAT DISTRIBUTION, AND SEX-HORMONES IN MEN [J].
HAFFNER, SM ;
KARHAPAA, P ;
MYKKANEN, L ;
LAAKSO, M .
DIABETES, 1994, 43 (02) :212-219
[10]   Low levels of endogtenous androgens increase the risk of atherosclerosis in elderly men: The Rotterdam study [J].
Hak, AE ;
Witteman, JCM ;
de Jong, FH ;
Geerlings, MI ;
Hofman, A ;
Pols, HAP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (08) :3632-3639